Revascularization of ischemic tissues is a major barrier to restoring tissue function in many pathologies. Delivery of pro-angiogenic factors has shown some benefit, but it is difficult to recapitulate the complex set of factors required to form stable vasculature. Cell-based therapies and pre-vascularized tissues have shown promise, but the former require time for vascular assembly in situ while the latter require invasive surgery to implant vascularized scaffolds. Here, we developed cell-laden fibrin microbeads that can be pre-cultured to form primitive vascular networks within the modular structures. These microbeads can be delivered in a minimally invasive manner and form functional microvasculature in vivo. Microbeads containing endothelial cells and stromal fibroblasts were pre-cultured for 3Â days in vitro and then injected within a fibrin matrix into subcutaneous pockets on the dorsal flanks of SCID mice. Vessels deployed from these pre-cultured microbeads formed functional connections to host vasculature within 3Â days and exhibited extensive, mature vessel coverage after 7Â days in vivo. Cellular microbeads showed vascularization potential comparable to bulk cellular hydrogels in this pilot study. Furthermore, our findings highlight some potentially advantageous characteristics of pre-cultured microbeads, such as volume preservation and vascular network distribution, which may be beneficial for treating ischemic diseases.
Injectable pre-cultured tissue modules catalyze the formation of extensive functional microvasculature in vivo.
可注射的预培养组织模块可催化体内广泛功能性微血管的形成
阅读:8
作者:Friend Nicole E, Rioja Ana Y, Kong Yen P, Beamish Jeffrey A, Hong Xiaowei, Habif Julia C, Bezenah Jonathan R, Deng Cheri X, Stegemann Jan P, Putnam Andrew J
| 期刊: | Scientific Reports | 影响因子: | 3.900 |
| 时间: | 2020 | 起止号: | 2020 Sep 23; 10(1):15562 |
| doi: | 10.1038/s41598-020-72576-5 | 研究方向: | 心血管 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
